We are live on
!
Find out more
SCM
Sirios Capital Management Portfolio holdings
AUM
$825M
1-Year Est. Return
50.18%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+50.18%
3 Year Est. Return
+155.9%
5 Year Est. Return
+187.16%
10 Year Est. Return
+610.56%
AUM
$1.79B
AUM Growth
-$291M
(-14%)
Cap. Flow
-$396M
Cap. Flow
% of AUM
-22.06%
Top 10 Holdings %
Top 10 Hldgs %
55.34%
Holding
50
New
3
Increased
13
Reduced
23
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affiliated Managers Group
AMG
|
+$34.3M |
| 2 |
VEON
VEON
|
+$17.8M |
| 3 |
McDonald's
MCD
|
+$14.6M |
| 4 |
Valvoline
VVV
|
+$14.3M |
| 5 |
VRNT
Verint Systems
VRNT
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$70.8M |
| 2 |
Bank of America
BAC
|
+$48.3M |
| 3 |
Gilead Sciences
GILD
|
+$48M |
| 4 |
Invesco
IVZ
|
+$35.4M |
| 5 |
RAX
Rackspace Hosting Inc
RAX
|
+$31.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.8% |
| 2 | Healthcare | 19.84% |
| 3 | Financials | 18.44% |
| 4 | Communication Services | 12.98% |
| 5 | Consumer Staples | 7.39% |
Similar funds
FPCP
MA
VT
FSA
CCM
ECM
AC
RIA
Sirios Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Sirios Capital Management held 50 positions worth $1.79B, down 14% from $2.08B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Sirios Capital Management withdrew a net $396M in Q3 2016, closing 11 positions and reducing 23 holdings. Its most notable exit was Gilead Sciences, an estimated $48M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Sirios Capital Management opened a new position in VEON worth $15.4M.
- Sirios Capital Management's largest Q3 2016 buy was VEON: 177,525 shares worth $15.4M.
- Sirios Capital Management added most to Affiliated Managers Group in Q3 2016, an estimated $34.3M increase.
- Sirios Capital Management's biggest Q3 2016 reduction was Allergan plc, cutting an estimated $70.8M.
- Sirios Capital Management fully exited Gilead Sciences in Q3 2016, selling an estimated $48M.
- Sirios Capital Management's ten largest holdings make up 55% of its $1.79B portfolio in Q3 2016.
- Sirios Capital Management opened 3 new positions and closed 11 in Q3 2016.
- Sirios Capital Management's portfolio value fell 14% quarter-over-quarter to $1.79B.
Based on Sirios Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.